Lab now supporting COVID-19 testing efforts in response to the pandemic

Our team has over 20 years of experience building and operating high-complexity CLIA laboratories. Members of our team have brought multiple tests to market, particularly novel prostate cancer diagnostics. We are closely affiliated with the University of Michigan.

LynxDx, a biotechnology startup, is committed to the health of our community during the COVID-19 pandemic. We have focused our diagnostic laboratory to provide testing at-scale, particularly for our most vulnerable and high-risk populations.

Your facility has a physician’s order that permits patient samples to be collected

A medical professional collects patient samples via nasal or oral swab

Samples are packaged in transport media and sent to our laboratory

Our CLIA-licensed lab processes the samples using RNA isolation and PCR

Results are reported back to your facility within 24 hours

CLIA-certified (high complexity)

qPCR-based antigen detection

24-hour turnaround time

Both nasopharyngeal and

oral swabs

100% specificity

FDA-approved Thermo

Fisher assay

Reimbursable by insurance

Can process hundreds

of tests/day